The five criteria for metabolic syndrome look identical on paper for men and women, but two of the cutoffs are different by sex, and the biology around them diverges more than the definitions suggest.
Quick answer: Women and men are diagnosed with metabolic syndrome by the same five measurements, but the waist cutoff (35 inches for women, 40 for men) and the HDL cutoff (below 50 for women, below 40 for men) differ. Before menopause, women have lower rates than men of the same age; after menopause, rates climb and often overtake men’s. PCOS, gestational diabetes, and pregnancy history add risk pathways that men do not have. For both sexes, the practical steps are the same measurements, but the questions worth asking are different.
Where the criteria differ
Metabolic syndrome is three or more of: elevated waist circumference, triglycerides at or above 150 mg/dL, low HDL, blood pressure at or above 130/85 or treated, and fasting glucose at or above 100 or treated. The calculator applies these and the complete guide explains them.
Waist. The common thresholds are 40 inches (102 cm) for men and 35 inches (88 cm) for women, reflecting the fact that women carry more subcutaneous fat at a given waist size and that visceral fat accumulates at smaller circumferences. Some definitions use lower cutoffs for people of South Asian, East Asian, and some other ancestries, for both sexes.
HDL. Women typically run higher HDL than men because of estrogen, so the threshold is set higher: below 50 mg/dL for women versus below 40 for men. A woman with an HDL of 45 meets the criterion; a man with 45 does not.
Triglycerides, blood pressure, and fasting glucose use the same cutoffs regardless of sex.
What the research shows about prevalence and risk
Large national surveys show that in early adulthood men have higher rates of metabolic syndrome than women, driven by more abdominal fat and higher triglycerides. From roughly the fifth decade onward, women’s rates rise faster, and in older age groups women often have equal or higher prevalence. The crossover tracks with menopause.
The consequences also differ. In pooled observational data, metabolic syndrome is associated with a larger relative increase in cardiovascular risk in women than in men, meaning that for a woman, meeting the criteria shifts her risk more from where it started. Diabetes, when it develops, erases more of women’s usual cardiovascular advantage than it does for men. Observational studies cannot prove causation, but the pattern is consistent across cohorts.
What the research does not show is a different treatment approach by sex. Lifestyle trials, including the large diabetes prevention trials, enrolled both and found similar benefit. The dietary pattern article applies to everyone.
Factors specific to women
Menopause. Falling estrogen shifts fat storage toward the abdomen, lowers HDL, and raises LDL and triglycerides, often without a change in body weight. Many women see two or three criteria appear within a few years of menopause while the scale barely moves, which is why waist measurement matters more than weight in this window. This is the Storage Load shifting under a hormonal change in the Regulatory Load.
PCOS. Polycystic ovary syndrome is driven in large part by insulin resistance, and women with PCOS have substantially higher rates of metabolic syndrome at younger ages, including lean women with PCOS. A PCOS diagnosis is a reason to check all five criteria early and to estimate insulin resistance with fasting insulin and the HOMA-IR calculator. Myo-inositol has its best trial evidence in this group, covered in the supplements hub.
Gestational diabetes and pregnancy history. A history of gestational diabetes carries a high lifetime risk of type 2 diabetes and metabolic syndrome, and that risk persists even after a normal postpartum glucose test. Preeclampsia history is also linked to later hypertension and metabolic syndrome. Both belong in the medical history a clinician considers when deciding how often to screen.
Hormonal contraception and hormone therapy. Some formulations raise triglycerides or blood pressure modestly. This does not mean they are off the table; it means those two numbers should be checked after starting one.
Factors specific to men
Men accumulate visceral fat earlier and at lower body weights, which is why the waist threshold is higher yet men still meet it more often in midlife. Low testosterone is associated with metabolic syndrome in both directions: abdominal obesity suppresses testosterone, and low testosterone promotes abdominal fat. Observational data link the two strongly; trials of testosterone replacement show mixed metabolic effects and carry their own risks, so this is a specialist conversation, not a supplement one.
Men are also less likely to have routine preventive visits in their thirties and forties, so the first measurement of the five criteria often happens later and shows more of them. Sleep apnea, which is more common in men at a given age, independently raises blood pressure and fasting glucose; the sleep apnea article covers when to ask for a sleep study.
How to read your own numbers
Use the sex-specific cutoffs for waist and HDL, and remember that lab reports often flag by a generic reference range rather than the metabolic syndrome threshold. A woman’s HDL of 48 may be unflagged and still count. Fasting glucose and A1C together give a better picture than either alone. Because symptoms are usually absent, the numbers are the whole story.
Safety and medications
Several of the supplements people consider for metabolic syndrome carry sex-specific cautions. Bitter melon and fenugreek should be avoided in pregnancy and discussed before trying to conceive. Inositol needs caution with lithium. High-dose vitamin D in excess raises calcium, which matters more for people on thiazide diuretics, often prescribed for blood pressure. Men on testosterone therapy should know it can raise hematocrit and affect lipids. None of this replaces a review with your prescriber.
Hypoglycemia warning: Combining any blood-sugar-active supplement with insulin, sulfonylureas, or other glucose-lowering medicines can push glucose too low. Symptoms include shakiness, sweating, confusion, and a fast heartbeat. Do not add a supplement to a medication plan without your prescriber’s knowledge.
Questions to bring to your appointment
- Using the cutoffs for my sex, how many of the five criteria do I meet, and what are the actual values?
- For women: does my history of PCOS, gestational diabetes, or preeclampsia change how often I should be screened?
- For women near or after menopause: should we track waist and lipids more closely over the next few years, even if my weight is stable?
- For men: is it worth checking testosterone or screening for sleep apnea given my waist and blood pressure?
- Do any of my hormonal medications affect triglycerides or blood pressure, and when were those last checked?
- Can we add a fasting insulin so I can estimate insulin resistance before glucose rises?
For background, see MedlinePlus on metabolic syndrome and the PubMed literature on sex differences in metabolic syndrome.
About the author: Charles Kirkland is the founder of Metabolic Clarity Labs and author of The Journey Back. He is not a physician. This is general education, not a medically reviewed treatment plan.
Sources checked October 29, 2026. Discuss personal decisions with a qualified clinician or pharmacist. Do not start, stop, or change prescribed treatment based on this article.
Leave a Reply